How High Cost Oncology Drugs Are Changing Specialty Pharmacy

Jonathan Van Lare, PharmD, director of Clinical Services at Pharmacy Advantage, discusses the impact of oncology medications and how specialty pharmacies can adjust.

Related Content:

InterviewsSpecialty PharmacyOncology

Treatment with Ofatumumab Increases Number of Patients Who Achieve No Evidence of Disease Activity for MS

Bringing Oncology Pharmacy Leaders, Payers Together to Address Unmet Educational Needs in the Field

Oncology Overview: Sonidegib (Odomzo) for Locally Advanced Basal Cell Carcinoma